This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
moving-average-crossover: Archive
NIO Inc. (NIO) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
NIONegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?
by Zacks Equity Research
MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MGTXNegative Net Change CRMDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Intellicheck Mobilisa (IDN): Can Its 25.4% Jump Turn into More Strength?
by Zacks Equity Research
Intellicheck Mobilisa (IDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
IDNNegative Net Change REZIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Guardian Pharmacy (GRDN) Soars 9.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
GRDNNegative Net Change AKBAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last?
by Zacks Equity Research
United Therapeutics (UTHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
UTHRNegative Net Change USNANegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Insmed (INSM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
INSMNegative Net Change KROSPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Marex Group PLC (MRX): Can Its 5.9% Jump Turn into More Strength?
by Zacks Equity Research
Marex Group PLC (MRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MRXPositive Net Change MFICNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Unity Software (U) Surges 13.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Unity Software (U) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ANETPositive Net Change UPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Dell Technologies (DELL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
DELLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Entergy (ETR) Surges 6.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Entergy (ETR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
ETRPositive Net Change XELPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today